These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders. Orsulak PJ; Schildkraut JJ; Schatzberg AF; Herzog JM Biol Psychiatry; 1978 Dec; 13(6):637-47. PubMed ID: 737252 [TBL] [Abstract][Full Text] [Related]
16. Effects of neuroleptics on platelet monoamine oxidase activity. Ho BT; Smith RC; Kralik P; Allen R; Schoolar J; Khan M; DeJohn C Biol Psychiatry; 1982 Aug; 17(8):885-95. PubMed ID: 6126230 [TBL] [Abstract][Full Text] [Related]
17. Platelet MAO activity and long-term outcome in schizophrenia and schizoaffective disorder. Malas KL; van Kammen DP Am J Psychiatry; 1983 Jun; 140(6):794-6. PubMed ID: 6846644 [TBL] [Abstract][Full Text] [Related]
18. Kinetic constants of platelet monoamine oxidase in schizophrenia. Jackman HL; Meltzer HY Am J Psychiatry; 1983 Aug; 140(8):1044-7. PubMed ID: 6869590 [TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle MAO activity in the major psychoses. Relationship with platelet and plasma MAO activities. Meltzer HY; Arora RC Arch Gen Psychiatry; 1980 Mar; 37(3):333-9. PubMed ID: 7362420 [TBL] [Abstract][Full Text] [Related]